| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/23/2003 | US20030018025 Psychological disorders, antidepressants, Parkinson's disease |
| 01/23/2003 | US20030018012 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | CA2451566A1 Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 01/23/2003 | CA2446726A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 01/23/2003 | CA2418173A1 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 01/23/2003 | CA2417156A1 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient |
| 01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
| 01/22/2003 | EP1277744A1 Oxadiazole derivatives having anticancer effects |
| 01/22/2003 | EP1277743A1 Oxa(thia)zolidine derivative and anti-inflammatory drug |
| 01/22/2003 | EP1277738A1 Condensed heteroaryl derivatives |
| 01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1276741A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
| 01/22/2003 | EP1276738A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/22/2003 | EP1276726A2 Substituted phenyl farnesyltransferase inhibitors |
| 01/22/2003 | EP1276725A2 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 01/22/2003 | EP1276723A2 Pyrazole compounds having anti proliferative activity |
| 01/22/2003 | EP1276720A2 2-acyl indol derivatives and their use as anti-tumour agents |
| 01/22/2003 | EP1030835B1 Urea derivatives and their use as integrin inhibitors |
| 01/22/2003 | EP0909174A4 Treatment of cystic disease with tnf-alpha |
| 01/22/2003 | EP0898562B1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 01/22/2003 | EP0782575B1 Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/22/2003 | CN1392874A Cyclic amidine compounds |
| 01/22/2003 | CN1099413C Certain fused N-pyrrolylaniline: new class of GABA brain receptor ligand |
| 01/21/2003 | US6509469 Process for the production of pyridine derivatives |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/21/2003 | US6509362 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 01/21/2003 | US6509357 1-aryl or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509331 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2003 | US6509328 Glutamate receptor antagonists |
| 01/21/2003 | US6508957 Fluorescent maleimides and uses thereof |
| 01/16/2003 | WO2003004493A1 Novel compounds, their preparation and use |
| 01/16/2003 | WO2003004486A2 Process for preparing isocoumarins |
| 01/16/2003 | WO2003004485A1 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004475A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004028A1 Tetrahydroquinoline derivatives |
| 01/16/2003 | WO2003004027A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | WO2003004023A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 01/16/2003 | WO2003004022A1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
| 01/16/2003 | WO2002051837A3 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 01/16/2003 | WO2002050062A3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 01/16/2003 | WO2002012196A3 Lactam compounds and their use as inhibitors of serine proteases and method |
| 01/16/2003 | US20030013894 Comprises conversion of oxalamide to dithiooxalamide, followed by conversion of the dithiooxalamide to either a 4,5-bisimino-(1,3)dithiolane or 2,3-bisimino-(1,4)dithiane |
| 01/16/2003 | US20030013892 Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids |
| 01/16/2003 | US20030013886 Such as (E)-1-(2-Pyridyl)-2-styryl-1H-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 01/16/2003 | US20030013875 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013744 3,4-diaryl thiophenes and analogs thereof having use as anti-inflammatory agents |
| 01/16/2003 | US20030013742 Antiinflammatory agents; skin disorders |
| 01/16/2003 | US20030013724 Novel prolines as antimicrobial agents |
| 01/16/2003 | US20030013712 Antiinflammatory agents |
| 01/16/2003 | US20030013706 Autoimmune disease; antiinflammatory agents |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/16/2003 | CA2454613A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | CA2452646A1 Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatement ofurinary incontinence |
| 01/16/2003 | CA2448913A1 Sulfone containing bicyclic aromatic ring compounds, their preparation and use as nicotinic acetyl-chloine receptors |
| 01/15/2003 | EP1275644A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1275389A1 Compositions containing C7 Taxanes |
| 01/15/2003 | EP1274706A1 Pyrazoles for inhibiting protein kinases |
| 01/15/2003 | EP1274705A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274683A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 01/15/2003 | EP1274424A1 Compounds and methods |
| 01/15/2003 | EP0974584B1 Fused ring compounds, process for producing the same and use thereof |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0722442B1 Polyazacycloalkanes as dichelants |
| 01/15/2003 | EP0713483B1 Amidine derivatives with nitric oxide synthetase activities |
| 01/15/2003 | EP0649412B1 Pharmaceutical pyridine compounds |
| 01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391563A Therapeutic quinazoline derivatives |
| 01/15/2003 | CN1391562A Quinazoline derivatives as pharmaceuticals |
| 01/15/2003 | CN1391560A 喹唑啉衍生物 Quinazoline derivatives |
| 01/15/2003 | CN1391558A Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 01/15/2003 | CN1391556A IL-8 receptor antagonists |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/15/2003 | CN1391475A Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1390834A Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 01/14/2003 | US6506901 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506777 Method for modulation of CCR-3 or CCR-5 chemokine receptor activity in a mammal in need thereof to treat asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis, which comprises the administration of an |
| 01/14/2003 | US6506770 Antiviral compounds |
| 01/14/2003 | US6506747 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; |
| 01/14/2003 | US6506538 Ophthalmic lenses, contact lenses, solar protection glasses, filters, camera optics or photographic apparatus optics or other optical devices |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |
| 01/14/2003 | US6506507 Methine compound, material for organic luminescence element, and organic luminescence element using the same |
| 01/14/2003 | CA2217516C Triazole antifungal agent |
| 01/14/2003 | CA2217477C Tricyclic compounds useful for inhibition of farnesyl protein transferase |